Pharma to register 7-9% growth in FY 2021; 8-11% in FY2022: ICRA
With inelastic demand for drugs and resumption of production to the near pre-COVID levels by Q3 FY 2021, revenue growth in FY 2021 is expected to be 7-9% in FY2021 according to leading credit agency ICRA.


































